Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-10

FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s Supplemental Application for CLOZAPINE, a generic version of clozapine under ANDA 202873. The approval covers the generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)